Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 22, 2008

View Archived Issues

Insights into the mechanism of action of maspin

Novel compounds for gastrointestinal disorders revealed in recent patents

Recent Daiichi Sankyo patents impart new coagulation factor Xa inhibitors

Novel agents for rheumatoid arthritis disclosed in recent patent literature

Non-brain-penetrant CB1 antagonists reduce weight in vivo

CRADA extension for BioDiem's live attenuated influenza vaccine program

Amorfix shows efficacy of DSE monoclonal antibodies in ASL mouse model

Lorus Therapeutics rounds up Q1 developments

ACE-031 begins phase I testing for loss of muscle

Peplin completes acquisition of Neosil for USD 6.7 million in an all-stock transaction

Pipex Pharmaceuticals changes name to Adeona Pharmaceuticals

FDA issues complete response to AMAG's NDA for ferumoxytol

FDA puts back PDUFA date for Takeda's TAK-390MR NDA by three months

Daiichi Sankyo acquires 52.5% of the equity share capital of Ranbaxy for USD 736 million

Peregrine completes enrollment in first stage of phase II trial of bavituximab in NSCLC

Biotec Pharmacon presents update on development of SBG

Archemix and Lilly sign agreement for R&D and intellectual property in aptamers

4SC reports results from phase I trial with cancer drug candidate 4SC-201

Avigen's AV-650 did not meet efficacy endpoints in phase IIb MS trial

Discovery submits complete response to May 2008 FDA approvable letter for Surfaxin

Raptor initiates patient dosing in phase IIa clinical trial of cysteamine in NASH

GeoVax ships DNA and MVA vaccines to HVTN for phase IIa human clinical trial

Novartis is to acquire pulmonary business from Nektar for USD 115 million

Gastrointestinal prokinetic 5-HT4 receptor agonist DA-6566 described

UPLIFT study reveals long-term effects of tiotropium in COPD patients

Saiko-keishi-to relieves pain in patients with classical trigeminal neuralgia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...